blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2970874

EP2970874 - METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.07.2019
Database last updated on 02.07.2024
FormerThe patent has been granted
Status updated on  17.08.2018
FormerGrant of patent is intended
Status updated on  03.04.2018
FormerExamination is in progress
Status updated on  27.01.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799 / US
[2016/03]
Inventor(s)01 / WU, Jian
3117 216th Place SE
Bothell, Washington 98021 / US
02 / DAVERN, Sean
2929 1st Avenue
Unit 401
Seattle, Washington 98121 / US
03 / PETROVAN, Simina, Crina
23819 23rd Avenue West
Bothell, Washington 98021 / US
04 / BRANDENSTEIN, Michael, Charles
14704 204th Place NE
Woodinville, Washington 98077 / US
05 / LINDAHL, Katherine, Rose
4250 34th Avenue West
Seattle, Washington 98199 / US
06 / LILLIE, Shawn, Erik
2418 43rd Avenue SE
Puyallup, Washington 98374 / US
 [2016/03]
Representative(s)Dörries, Hans Ulrich
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[2016/03]
Application number, filing date14714521.310.03.2014
[2016/03]
WO2014US22738
Priority number, dateUS201361784639P14.03.2013         Original published format: US 201361784639 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014159259
Date:02.10.2014
Language:EN
[2014/40]
Type: A1 Application with search report 
No.:EP2970874
Date:20.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 02.10.2014 takes the place of the publication of the European patent application.
[2016/03]
Type: B1 Patent specification 
No.:EP2970874
Date:19.09.2018
Language:EN
[2018/38]
Search report(s)International search report - published on:EP02.10.2014
ClassificationIPC:C12N1/38, C12P21/00, C12N5/00, C07K16/00
[2016/03]
CPC:
C12P21/005 (EP,US); C07K16/00 (EP,US); C12N1/38 (EP,US);
C12N5/0037 (EP,US); C07K2317/14 (EP,US); C07K2317/41 (EP,US);
C12N2500/32 (EP,US); C12N2500/34 (EP,US); C12N2510/02 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/03]
Extension statesBA14.10.2015
ME14.10.2015
TitleGerman:VERFAHREN ZUR ERHÖHUNG DES MANNOSEGEHALTS REKOMBINANTER PROTEINE[2016/03]
English:METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS[2016/03]
French:MÉTHODES POUR AUGMENTER LA TENEUR EN MANNOSE DE PROTÉINES RECOMBINANTES[2016/03]
Entry into regional phase14.10.2015National basic fee paid 
14.10.2015Designation fee(s) paid 
14.10.2015Examination fee paid 
Examination procedure14.10.2015Amendment by applicant (claims and/or description)
14.10.2015Examination requested  [2016/03]
26.01.2017Despatch of a communication from the examining division (Time limit: M04)
19.05.2017Reply to a communication from the examining division
27.07.2017Despatch of a communication from the examining division (Time limit: M04)
27.11.2017Reply to a communication from the examining division
04.04.2018Communication of intention to grant the patent
01.08.2018Fee for grant paid
01.08.2018Fee for publishing/printing paid
01.08.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18194714.4  / EP3434760
EP22179111.4  / EP4141104
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.01.2017
Opposition(s)20.06.2019No opposition filed within time limit [2019/35]
Fees paidRenewal fee
10.03.2016Renewal fee patent year 03
10.03.2017Renewal fee patent year 04
13.03.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL19.09.2018
HR19.09.2018
MK19.09.2018
RS19.09.2018
SM19.09.2018
NO19.12.2018
[2022/31]
Former [2019/27]AL19.09.2018
HR19.09.2018
RS19.09.2018
SM19.09.2018
NO19.12.2018
Former [2019/12]AL19.09.2018
HR19.09.2018
RS19.09.2018
NO19.12.2018
Former [2019/11]HR19.09.2018
RS19.09.2018
NO19.12.2018
Former [2019/08]NO19.12.2018
Cited inInternational search[XI]JPH06292592  (SNOW BRAND MILK PRODUCTS CO LTD) [X] 1-3,8,16,65-68 * the whole document * [I] 7,12-14,17;
 [XI]WO9928455  (ROCHE DIAGNOSTICS GMBH [DE], et al) [X] 1-6,8,16,66,68 * examples 5,7 * [I] 7,12-14,17;
 [XI]WO2004008100  (IMMUNEX CORP [US], et al) [X] 1-3,8,16,64-68 * example 1 * [I] 7,12-14,17;
 [XI]  - GRAMER M J ET AL, "Modulation of Antibody Galactosylation Through Feeding of Uridine, Manganese Chloride, and Galactose", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 108, no. 7, doi:10.1002/BIT.23075, ISSN 0006-3592, (20110701), pages 1591 - 1602, (20110218), XP002688515 [X] 1,3-6,9-11,15,16,64-68 * table 1 * [I] 7,12-14,17

DOI:   http://dx.doi.org/10.1002/bit.23075
 [A]  - WONG DANNY CHEE FURNG ET AL, "Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, (20050120), vol. 89, no. 2, ISSN 0006-3592, pages 164 - 177, XP009142862 [A] 1-68 * the whole document *
 [A]  - EFREN PACIS ET AL, "Effects of cell culture conditions on antibody N-linked glycosylation-what affects high mannose 5 glycoform", BIOTECHNOLOGY AND BIOENGINEERING, (20111001), vol. 108, no. 10, doi:10.1002/bit.23200, ISSN 0006-3592, pages 2348 - 2358, XP055080567 [A] 1-68 * the whole document *

DOI:   http://dx.doi.org/10.1002/bit.23200
 [A]  - HILLS A E ET AL, "METABOLIC CONTROL OF RECOMBINANT MONOCLONAL ANTIBODY N-GLYCOSYLATION IN GS-NS0 CELLS", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, (20011020), vol. 75, no. 2, doi:10.1002/BIT.10022, ISSN 0006-3592, pages 239 - 251, XP001206784 [A] 1-68 * table 1 *

DOI:   http://dx.doi.org/10.1002/bit.10022
 [A]  - JAMES 1 REARICKS ET AL, "Glucose Starvation Alters Lipid-linked Oligosaccharide Biosynthesis in Chinese Hamster Ovary Cells", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19810625), vol. 256, no. 12, pages 6255 - 6261, XP055124811 [A] 1-68 * the whole document *
by applicantUS4695623
 AU588819B
 US4897471
 EP0367566
 US4968607
 EP0460846
 US5075222
 US5149792
 US5272064
 WO9410308
 WO9428391
 US5395760
 WO9701633
 US5610279
 US5767064
 US5856296
 US5981713
 US6015938
 US6096728
 US6204363
 US6235883
 WO0136637
 US6271349
 US6337072
 US6544424
 WO2012145682
 WO2013006479
 US8354105
    - GOETZE ET AL., GLYCOBIOLOGY, (2011), vol. 21, pages 949 - 59
    - YU ET AL., MABS, (2012), vol. 4, pages 475 - 87
    - PACIS, BIOTECHNOL BIOENG, (2011), vol. 108, pages 2348 - 2358
    - CHEE FURNG WONG ET AL., BIOTECHNOL BIOENG, (2005), vol. 89, pages 164 - 177
    - AHN, BIOTECHNOL BIOENG, (2008), vol. 101, pages 1234 - 44
    - HUBBARD; IVATT, ANN. REV. BIOCHEM., (1981), vol. 50, pages 555 - 583
    - VOISARD ET AL., BIOTECHNOLOGY AND BIOENGINEERING, (2003), vol. 82, pages 751 - 65
    - STETTLER, BIOTECHNOL BIOENG., (20061220), vol. 95, no. 6, pages 1228 - 33
    - KAUFMAN, R.J., LARGE SCALE MAMMALIAN CELL CULTURE, (1990), pages 15 - 69
    - BRASEL ET AL., BLOOD, (1996), vol. 88, pages 2004 - 2012
    - KAUFMAN ET AL., J. BIOL CHEM, (1988), vol. 263, pages 6352 - 6362
    - MCKINNON ET AL., J. MOL ENDOCRINOL, (1991), vol. 6, pages 231 - 239
    - WOOD ET AL., J. IMMUNOL., (1990), vol. 145, pages 3011 - 3016
    - URLAUB ET AL., PROC NATL ACAD SCI USA, (1980), vol. 77, pages 4216 - 4220
    - KAUFMAN R.J., METH ENZYMOL, (1990), vol. 185, pages 537 - 566
    - MAISONPIERRE ET AL., SCIENCE, (1997), vol. 277, no. 5322, pages 55 - 60
    - RUEGG; PYTELA, GENE, (1995), vol. 160, pages 257 - 62
    - THOMPSON AND LOTZE, The Cytokine Handbook, ACADEMIC PRESS, (2003), vol. 1, 2
    - DO; CHEN-KIANG, CVTOKINE GROWTH FACTOR REV., (2002), vol. 13, no. 1, pages 19 - 25
    - LOVEJOY ET AL., SCIENCE, (1993), vol. 259, pages 1288 - 1293
    - HARBURY ET AL., SCIENCE, (1993), vol. 262, pages 1401 - 05
    - HARBURY ET AL., NATURE, (1994), vol. 371, pages 80 - 83
    - HÅKANSSON ET AL., STRUCTURE, (1999), vol. 7, pages 255 - 64
    - SCHMELZER; MILLER, BIOTECHNOL. PROG., (2002), vol. 18, pages 346 - 353
    - SCHMELZER; MILLER, BIOTECHNOL. BIOENG, (20020215), vol. 77, no. 4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.